Merck Balance Sheet
NYSE: MRKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:02 PM ET · Delayed 15 min
Merck financial position
At the end of fiscal 2025, Merck reported total assets of $136.87 billion, up 16.9% from a year earlier against total liabilities of $84.20 billion. Shareholders' equity stood at $52.61 billion, or 38.4% of assets. The company held $14.56 billion in cash and equivalents against $49.34 billion of debt, a net debt position of $34.77 billion.
The current ratio (current assets divided by current liabilities) was 1.54, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.94.
Summary generated from market data by MetaCap's automated system. Methodology
Merck balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 14.56B | 13.24B | 6.84B | 12.69B | 8.10B | 8.05B | 9.68B | 7.96B | 6.09B | 6.51B |
| Short-Term Investments | 0 | 447.00M | 252.00M | 498.00M | 0 | 0 | 774.00M | 899.00M | 2.41B | 7.83B |
| Receivables | 11.78B | 10.28B | 10.35B | 9.45B | 9.23B | 6.80B | 6.78B | 7.07B | 6.87B | 7.02B |
| Inventory | 6.66B | 6.11B | 6.36B | 5.91B | 5.95B | 5.55B | 5.98B | 5.44B | 5.10B | 4.87B |
| Total Current Assets | 43.52B | 38.78B | 32.17B | 35.72B | 30.27B | 27.76B | 27.48B | 25.88B | 24.77B | 30.61B |
| Property, Plant & Equipment | 25.32B | 23.78B | 23.05B | 21.42B | 19.28B | 17.00B | 14.30B | 13.29B | 12.44B | 12.03B |
| Goodwill | 21.58B | 21.67B | 21.20B | 21.20B | 21.26B | 18.88B | 18.07B | 18.25B | 18.28B | 18.16B |
| Intangible Assets | 26.68B | 16.37B | 18.01B | 20.27B | 22.93B | 14.10B | 14.20B | 13.10B | 14.18B | 17.30B |
| Long-Term Investments | 956.00M | 463.00M | 252.00M | 1.01B | 370.00M | 785.00M | 1.47B | 6.23B | 12.13B | 11.42B |
| Total Assets | 136.87B | 117.11B | 106.67B | 109.16B | 105.69B | 91.59B | 84.40B | 82.64B | 87.87B | 95.38B |
| Accounts Payable | 4.40B | 4.08B | 3.92B | 4.26B | 4.61B | 4.33B | 3.74B | 3.32B | 3.10B | 2.81B |
| Short-Term Debt | 2.59B | 2.65B | 1.37B | 1.95B | 2.41B | 6.43B | 3.61B | 5.31B | 3.06B | 568.00M |
| Total Current Liabilities | 28.33B | 28.42B | 25.69B | 24.24B | 23.87B | 27.33B | 22.22B | 22.21B | 18.61B | 17.20B |
| Long-Term Debt | 46.75B | 34.46B | 33.68B | 28.75B | 30.69B | 25.36B | 22.74B | 19.81B | 21.35B | 24.27B |
| Total Liabilities | 84.20B | 70.73B | 69.04B | 63.10B | 67.44B | 66.18B | 58.40B | 55.76B | 53.30B | 55.07B |
| Shareholders' Equity | 52.61B | 46.31B | 37.58B | 45.99B | 38.18B | 25.32B | 25.91B | 26.70B | 34.34B | 40.09B |
| Retained Earnings | 73.08B | 63.07B | 53.90B | 61.08B | 53.70B | 47.36B | 46.60B | 42.58B | 41.35B | 44.13B |
| Total Debt | 49.34B | 37.11B | 35.05B | 30.69B | 33.10B | 31.79B | 26.35B | 25.11B | 24.41B | 24.84B |
| Net Cash (Debt) | -34.77B | -23.42B | -27.96B | -17.50B | -25.01B | -23.74B | -15.90B | -16.25B | -15.91B | -10.50B |
This table shows 10 annual periods of Merck's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow MRK's reporting calendar. What is a balance sheet?